HUDSON
BIOTECH
OUR PEPTIDES
Pure Peptides, Trusted Quality
Hudson Biotech manufactures a broad portfolio of peptides for clinical-trial and research applications. All peptides listed on this page are investigational compounds unless explicitly stated otherwise. None are approved by the FDA or any regulatory authority for the treatment, prevention, or cure of any disease or condition.
Peptide Portfolio
Explore our investigational peptide portfolio. Each program is supported by custom synthesis, analytical characterization, and documentation aligned with research and clinical-trial requirements.
Retatrutide (LY3437943)
Triple Hormone Receptor Agonist | GIP / GLP-1 / Glucagon
Key Identifier: NCT07467447
Key Identifier:
NCT07467447
Primary Area:
Obesity / metabolic disease
Status:
Investigational – not FDA approved
FDA Note:
Not approved for any indication and not permitted for compounding under federal law
Tirzepatide
Dual GIP / GLP-1 Receptor Agonist
Tirzepatide is described in FDA labeling as a dual GIP and GLP-1 receptor agonist. Registry sources reference a Phase 3 study (NCT07481747) in adults with obesity or overweight without type 2 diabetes.
Key Identifier:
NCT07481747
Primary Area:
Obesity / type 2 diabetes / weight management
Status:
Approved for specific indications; investigational for other uses
FDA Note:
Approved as Mounjaro and Zepbound for labeled indications only
BPC 157
15-Amino-Acid Investigational Peptide
BPC 157 is listed in FDA’s UNII database and remains investigational. Public records reference a Phase 2 study (NCT07437547) in acute grade II hamstring strain.
Key Identifier:
NCT07437547
Primary Area:
Soft tissue repair / sports medicine
Status:
Investigational – not FDA approved
FDA Note:
Not part of any FDA-approved drug; not on the 503A bulks list
Tesamorelin
GHRH Analog
Tesamorelin is FDA-approved for HIV-associated lipodystrophy. Investigational use includes liver fat reduction (NCT07481734).
Key Identifier:
NCT07481734
Primary Area:
HIV lipodystrophy / liver fat
Status:
Approved for limited use; investigational beyond labeled indications
FDA Note:
Not indicated for weight management
GHK-Cu (Copper Tripeptide-1)
Copper-Peptide Complex
GHK-Cu is an investigational peptide complex studied in wound healing. Public data reference a Phase 2 study (NCT07437586).
Key Identifier:
NCT07437586
Primary Area:
Wound healing / dermatology
Status:
Investigational – not FDA approved
FDA Note:
Potential risks include immunogenicity and peptide-related impurities
TB-500
Thymosin Beta-4 Fragment (17–23)
TB-500 is a peptide fragment associated with tissue repair research and cardiovascular applications.
Key Identifier:
NCT07487363
Primary Area:
Cardiovascular / tissue repair
Status:
Investigational – not FDA approved
FDA Note:
Listed by WADA as a prohibited substance in sport
Melanotan II
Synthetic Cyclic Heptapeptide | Alpha-Melanotropin Analog.
Melanotan II is a cyclic peptide studied for pigmentation-related applications, including vitiligo.
Key Identifier:
NCT07437560
Primary Area:
Pigmentation / melanocortin pathway
Status:
Investigational – not FDA approved
FDA Note:
Classified as an unapproved new drug with safety concerns
Custom Peptide Synthesis
Hudson Biotech provides custom peptide synthesis tailored to research and clinical-trial programs, with support across characterization, quality planning, and batch documentation needs.
- 01 Sequence confirmation and identity testing
- 02 Phase-appropriate purification
- 03 Impurity profiling and control
- 04 Stability planning and documentation
- 05 Batch release and certificate of analysis
Quality & Documentation
Robust documentation is critical for clinical research and supports quality control, study credibility, regulatory readiness, and reliable interpretation of investigational material performance.
- 01 Sequence-level identity confirmation
- 02 Phase-appropriate purity specifications
- 03 Impurity characterization and control
- 04 Stability data for handling and storage
- 05 Batch release documentation
- 06 CMC support for regulatory submissions
Compliance Information
Investigational Use Only:
All peptides are investigational unless stated otherwise. No approvals for therapeutic use are implied.
Research Use:
Intended solely for qualified research and clinical-trial applications. Not for consumer use.
ClinicalTrials.gov References:
Some entries may be mock or example records. Verify directly with official sources.
No Medical Advice:
Content is informational and intended for professional audiences only.